Stealth BioTherapeutics is an innovative biopharmaceutical company based in Chestnut Hill, MA, dedicated to developing therapies for mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. With a strong focus on patient-centered therapeutic development, their mission is to improve the quality of life for patients with mitochondrial disorders, for which there are currently no FDA-approved treatments.
Driven by a passion for patients and a belief in the potential of their science, Stealth BioTherapeutics works closely with patients, advocacy organizations, and healthcare providers to better understand the challenges faced by those with mitochondrial diseases. Their goal is to raise awareness of the unmet clinical needs in this field and deliver new treatment solutions for conditions such as dry age-related macular degeneration, a leading cause of blindness among older adults.
Generated from the website